Objective
We sought to compare myomectomy performed by laparotomy (LT), and 2 other modified approaches: ultraminilaparotomy (UMLT) and laparoscopically assisted UMLT for uterine fibroids with a size <8 cm and the number <5.
Study Design
A cohort study, including 79 (35.3%) women in the LT group, 71 (31.7%) in the UMLT group, and 74 (33.0%) in the laparoscopically assisted UMLT group, was conducted. The outcome was measured by comparing surgical parameters, immediate postoperative recovery, and therapeutic outcomes.
Results
The median follow-up was 52 months with similar recurrence rates in the 3 groups. The modified approaches had advantages not only in the surgical parameters, but also in postoperative recovery, compared to LT (all P < .05).
Conclusion
UMLT and laparoscopically assisted UMLT can be used successfully in place of LT in the management of uterine fibroids.
Uterine fibroids are the most common benign tumors of the uterus, and myomectomy is often advisable for symptomatic women who wish to preserve their childbearing capabilities. With the advances being made in techniques and instruments, the laparoscopic myomectomy (LM) has become popular, although it is a more complicated and technically challenging procedure with a long learning curve. A notable number of the original designs for LM will be ended by converting to conventional exploratory laparotomy (LT) or others.
Ultraminilaparotomy (UMLT) is defined as having an incision length of <4 cm. Laparoscopically assisted myomectomy (LAM) is a modification of LM for the purpose of reducing the technological difficulty, and includes easier identification of the uterine fibroids by the fingers or hands through a small wound, and easier and more definite repair of the uterus by conventional suture techniques.
This cohort study aimed to evaluate the long-term efficacy and outcome of myomectomy performed either through traditional LT or with 1 of 2 modified approaches: UMLT or laparoscopically assisted UMLT (LA-UMLT), for women with symptomatic uterine fibroids.
Materials and Methods
Patients
Between January 2002 and December 2003, all patients (n = 437) eligible for benign uterine myomas treated with myomectomy through LT, UMLT, and LA-UMLT were recruited for this cohort study ( Figure ). The patients, who had given informed consent, were treated with 1 of the above-mentioned procedures based on their willingness and preference after explaining the details and advantages of the 3 surgical approaches, including postoperative pain control through methods such as the continuous pain-control anesthesia system. This study was approved by the institutional review board.
To obtain a homogeneous series of cases with comparable surgical difficulty, all patients had to fulfill the criteria of uncomplicated myomas provided by the National Health Insurance Bureau in Taiwan, including: (1) absence of previous abdominal or pelvic surgery; (2) a number of visible uterine masses (myomas) ≤5 intramural or subserous myomas (without peduncle); (3) a maximum diameter of not >8 cm; and (4) an absence of prominent or significant pelvic adhesion on clinical evaluation. In addition, the patients had to fulfill the following 3 basic requirements: absence of preoperative or postoperative adjuvant therapy; absence of other pelvic pathologies, except fibroids; and a final follow-up in 2007. The phrase “symptomatic” meant any disturbance induced by fibroids that troubled one’s life, which has been described previously.
Operative procedures
All operations were performed under general endotracheal anesthesia with the patient in the Trendelenburg position and the bladder catheterized. Diluted vasopressin (1:60) was injected into the myometrium around the myoma nodules and directly into the fibroid tissue of the patients in the 3 groups to decrease intraoperative bleeding.
LT
In the LT group, an 8- to 12-cm transverse incision (Pfannenstiel incision) was made 1-2 cm below the pubic hairline, 2-4 cm above the pubic symphysis. The subcutaneous fat was incised and the abdominal fascia was opened transversely 2-3 cm above the skin incision to a width of 10-16 cm. The abdominal muscle was opened longitudinally on the midline and the peritoneum was visualized and opened longitudinally to reach the pelvic cavity. Subsequently, a self-retaining retractor or Balfour retractors (Sklar Instrument, West Chester, PA) were inserted through the abdominal breach and the bowel was packed upward with warm, wet pads. After examination of the uterus and adnexa, all intact fibroids were removed smoothly. The uterine defects were closed in a double layer with interrupted sutures of Vicryl 1-0 (polyglactin 910, W9464; Ethicon, Somerville, NJ). After controlling the hemostasis and repeated washing of the pelvic cavity, the wound was closed layer by layer.
UMLT
The operative procedure in the UMLT group was similar to that in the LT group, with some differences. First, a 2-4 cm (near 3 cm) transverse incision (modified Pfannenstiel incision) along the preoperative mark was made below the pubic hairline. The abdominal fascia was opened transversely to a width of 5-6 cm only. Second, the self-retaining retractor was replaced with small Deaver retractors (width 2.5 cm) or thyroid retractors (width 1.5 cm). The small end of the abdominal retractor (width 3 cm) was inserted just barely into the wound. During dissection, the instrument, the Backhaus towel clamp (Robbins Instruments Inc, Chatham, NJ), was applied as traction to the myomas toward the incision wound. Third, removal of the leiomyomas intact was not as easy as in LT. Larger leiomyomas were pared piece by piece, similar to the peeling of an apple, through a smaller wound.
LA-UMLT
In the LA-UMLT group, a pneumoperitoneum was established as usual. A 10-mm port was inserted through the umbilicus to introduce the videolaparoscopic system. Three other accessory 5-mm trocars were inserted into the abdomen to the left lower quadrant, right lower quadrant, and suprapubic area for use by the operative instruments and the suction irrigator cannula. The myomas were grasped and pulled with a second needle. After infiltration with diluted vasopressin (1:60), the myometrium was incised and the myoma removed. After completing the procedure, the carbon-dioxide insufflator and videolaparoscopic system were turned off temporarily. Then, we extended the incision wound of the suprapubic trocar up to 3 cm. The myomas were extracted and removed piece by piece through the suprapubic wound, as in the UMLT procedure. In addition, the entire uterus was carefully palpated by the fingers through the suprapubic wound to exclude residual fibroids, which might be missed by the videolaparoscopic system. As in the UMLT procedure, the myometrial defects were repaired through a suprapubic wound. After closure of the suprapubic wound, videolaparoscopy was used again to clean the abdominal cavity. The use of a drainage system (closed wound vacuum reservoir) was dependent on the operator’s preference and the surgical situation.
Evaluation parameters
The parameters we considered for comparing the 3 groups were the characteristics of the uterine fibroids, the surgical parameters, morbidity, and outcome. Surgical parameters included the final incision length of the surgical wound (centimeters), operative time (minutes), estimated blood loss (milliliters), time of removal of drainage, percentage of blood transfusion, morbidity, and failure. Morbidity included percentage of febrile morbidity (body temperature >37.5°C), maximal temperature, duration of febrile morbidity, and percentage of paralytic ileus. Patient discomfort consisted of time of paralytic ileus, hospital stay (days), visual analog scale, postoperative use of analgesics, and accumulative dosage of meperidine hydrochloride. The outcome evaluation mainly focused on recurrence: either the occurrence of symptoms or any detection of uterine fibroids. The parameters, including recurrence rate, interval between operation and detection of recurrence, number, maximal size, location, and association of the previous uterine fibroids, were recorded. Recurrence was defined as any detected tumor with a minimal diameter >1 cm after operation. The term “association” meant the detection of any recurrent uterine fibroids at the original operative site (area of tumor excision) during the follow-up after operation. All patients received >4 semiannual follow-ups and then were followed up annually or when the symptoms or signs recurred. Routine pelvic examination and ultrasound were used for every patient.
Statistical analysis
Statistical software (SPSS, Version 15.0; SPSS Inc, Chicago, IL) was used to analyze all data. Data were presented as the mean ± SD. The parametric-independent samples t test was used to compare the differences between the 3 groups, and χ 2 analysis was used for categorical variables. For all statistical evaluations, P < .05 was used to reject the null hypothesis.
Results
Of the 224 enrolled patients, 79 (35.3%) were in the LT group, 71 (31.7%) in the UMLT group, and 74 (33.0%) in the LA-UMLT group. The median follow-up was 52 months, ranging from 48-69 months. Baseline characteristics are shown in Table 1 . The suprapubic incision length was significantly longer in the LT group (9.0 ± 1.7 cm) than in the UMLT group (3.6 ± 0.5 cm) or LA-UMLT group (2.7 ± 0.5 cm) ( P < .001). Operative time in the UMLT group was less than that in the LA-UMLT group (98.0 ± 28.2 vs 106.3 ± 30.5 minutes; P < .05). Removal of the postoperative drainage system after LT (3.6 ± 1.0 d) was significantly delayed, compared with UMLT (2.5 ± 0.6 d) and LA-UMLT (2.6 ± 1.0 d) ( Table 2 ).
Basic data | LT (group 1) (n = 79) | UMLT (group 2) (n = 71) | LA-UMLT (group 3) (n = 74) | P value (1 vs 2) | P value (2 vs 3) | P value (1 vs 3) |
---|---|---|---|---|---|---|
Age, y | 39.2 ± 6.1 | 39.8 ± 7.7 | 42.7 ± 6.9 | .579 | .022 | .001 |
Body mass index, kg/m 2 | 22.9 ± 3.4 | 22.5 ± 4.5 | 23.0 ± 3.4 | .528 | .463 | .888 |
Fibroid data | ||||||
No. | 2.1 ± 1.2 | 1.9 ± 1.1 | 1.9 ± 1.1 | .232 | .797 | .325 |
Maximal diameter, cm | 6.8 ± 2.2 | 6.9 ± 2.0 | 6.3 ± 1.5 | .797 | .072 | .151 |
Main tumor location | ||||||
Anterior wall | 27.8% (22) | 28.2% (20) | 24.3% (18) | .965 | .599 | .620 |
Fundal wall | 24.1% (19) | 21.1% (15) | 20.3% (15) | .672 | .899 | .574 |
Posterior wall | 21.5% (17) | 19.7% (14) | 25.7% (19) | .786 | .392 | .545 |
Lateral wall | 26.6% (21) | 31.0% (22) | 29.7% (22) | .552 | .869 | .665 |
Surgical parameter | LT (group 1) (n = 79) | UMLT (group 2) (n = 71) | LA-UMLT (group 3) (n = 74) | P value (1 and 2) | P value (2 and 3) | P value (1 and 3) |
---|---|---|---|---|---|---|
Incision length, cm | 9.0 ± 1.7 | 3.6 ± 0.5 | 2.7 ± 0.5 | < .001 | < .001 | < .001 |
Operative time, min | 102.2 ± 27.6 | 98.0 ± 28.2 | 106.3 ± 30.5 | .361 | .037 | .178 |
Blood loss, mL | 117.4 ± 125.1 | 111.7 ± 108.4 | 92.3 ± 67.2 | .766 | .200 | .121 |
Time of removal of CWV, d | 3.6 ± 1.0 | 2.5 ± 0.6 | 2.6 ± 1.0 | .020 | .84 | .010 |
Blood transfusion | 2.5% (2) | 0% (0) | 1.4% (1) | .177 | .535 | .599 |
-500 mL | -500 mL | |||||
-500 mL | ||||||
Use of analgesic | ||||||
PCA, % | 39.2 | 22.5 | 2.7 | .028 | < .001 | < .001 |
Meperidine hydrochloride, % | 59.5 | 70.4 | 93.2 | .162 | < .001 | < .001 |
Meperidine hydrochloride dosage, mg | 134.6 ± 79.5 | 113.0 ± 58.1 | 111.6 ± 70.3 | .133 | .909 | .107 |